Sera Prognostics (SERA) Projected to Post Quarterly Earnings on Wednesday

Key Points

• Sera Prognostics (SERA) is set to announce its Q2 2025 earnings on August 6th, with analysts expecting an earnings per share of ($0.21) and revenue of $0.05 million.
• The company's CEO, Zhenya Lindgardt, sold 23,042 shares for approximately $32,950, which represents a 2.66% decrease in their holdings, and insiders have sold a total of 67,848 shares in the last ninety days.
• Wall Street analysts have upgraded Sera Prognostics from a "sell" rating to a "hold" rating, indicating a cautious optimism about the company's future performance.

Sera Prognostics (NASDAQ:SERA - Get Free Report) is expected to release its Q2 2025 earnings data before the market opens on Wednesday, August 6th. Analysts expect Sera Prognostics to post earnings of ($0.21) per share and revenue of $0.05 million for the quarter.

Sera Prognostics (NASDAQ:SERA - Get Free Report) last announced its earnings results on Wednesday, May 14th. The company reported ($0.20) earnings per share for the quarter, beating the consensus estimate of ($0.24) by $0.04. The company had revenue of $0.04 million during the quarter, compared to the consensus estimate of $0.06 million. Sera Prognostics had a negative return on equity of 51.35% and a negative net margin of 28,685.22%. On average, analysts expect Sera Prognostics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Sera Prognostics Stock Down 2.9%

Shares of Sera Prognostics stock traded down $0.08 during trading hours on Friday, hitting $2.70. 59,613 shares of the company's stock traded hands, compared to its average volume of 118,313. The stock has a 50 day simple moving average of $2.31 and a 200-day simple moving average of $3.41. The company has a market cap of $101.71 million, a PE ratio of -2.87 and a beta of 0.99. Sera Prognostics has a twelve month low of $1.37 and a twelve month high of $9.13.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Sera Prognostics from a "sell" rating to a "hold" rating in a research note on Saturday, June 21st.

Insider Transactions at Sera Prognostics

In other news, CEO Zhenya Lindgardt sold 23,042 shares of Sera Prognostics stock in a transaction that occurred on Monday, June 9th. The stock was sold at an average price of $1.43, for a total transaction of $32,950.06. Following the sale, the chief executive officer owned 844,209 shares of the company's stock, valued at approximately $1,207,218.87. The trade was a 2.66% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders have sold a total of 67,848 shares of company stock valued at $128,049 over the last quarter. Company insiders own 13.50% of the company's stock.

Sera Prognostics Company Profile

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.